Report Detail
Global Progesterone Market Insights, Forecast to 2025
- RnM2316520 |
- 06 June, 2019 |
- Global |
- 115 Pages |
- QYResearch |
- Pharma & Healthcare
Progesterone is the naturally occurring steroid hormone that is produced in adrenal glands, ovary, and placenta (during pregnancy).
The major factors that drive the growth of the progesterone market are growing incidences of diseases such as abnormal uterine bleeding, amenorrhea, kidney, breast, or uterine cancer, and AIDS.
The global Progesterone market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Progesterone market based on company, product type, end user and key regions.
This report studies the global market size of Progesterone in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Progesterone in these regions.
This research report categorizes the global Progesterone market by top players/brands, region, type and end user. This report also studies the global Progesterone market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
ESTRELLAS LIFE SCIENCES PRIVATE LIMITED
BIONPHARMA INC.
SOFGEN PHARMACEUTICALS
TEVA PHARMACEUTICALS INDUSTRIES LTD.
VIRTUS PHARMACEUTICALS LLC
BLUBELL PHARMA GROUP COMPANY
AQUATIC REMEDIES PVT. LTD.
INTAS PHARMACEUTICALS LTD.
SHANGHAI YIJING INDUSTRIAL CO., LTD.
WUHAN HONOR BIO-PHARM CO., LTD.
Market size by Product
Natural Progesterone
Synthetic Progesterone
Market size by End User
Regulation of the Menstrual Cycle
Dysfunctional Uterine Bleeding
Endometrial Cancer
Contraception
Hyperplastic Precursor Lesions
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Progesterone market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Progesterone market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Progesterone companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Progesterone submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Progesterone are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Progesterone market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Progesterone Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Progesterone Market Size Growth Rate by Product
- 1.4.2 Natural Progesterone
- 1.4.3 Synthetic Progesterone
- 1.5 Market by End User
- 1.5.1 Global Progesterone Market Size Growth Rate by End User
- 1.5.2 Regulation of the Menstrual Cycle
- 1.5.3 Dysfunctional Uterine Bleeding
- 1.5.4 Endometrial Cancer
- 1.5.5 Contraception
- 1.5.6 Hyperplastic Precursor Lesions
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Progesterone Market Size
- 2.1.1 Global Progesterone Revenue 2014-2025
- 2.1.2 Global Progesterone Sales 2014-2025
- 2.2 Progesterone Growth Rate by Regions
- 2.2.1 Global Progesterone Sales by Regions
- 2.2.2 Global Progesterone Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Progesterone Sales by Manufacturers
- 3.1.1 Progesterone Sales by Manufacturers
- 3.1.2 Progesterone Sales Market Share by Manufacturers
- 3.1.3 Global Progesterone Market Concentration Ratio (CR5 and HHI)
- 3.2 Progesterone Revenue by Manufacturers
- 3.2.1 Progesterone Revenue by Manufacturers (2014-2019)
- 3.2.2 Progesterone Revenue Share by Manufacturers (2014-2019)
- 3.3 Progesterone Price by Manufacturers
- 3.4 Progesterone Manufacturing Base Distribution, Product Types
- 3.4.1 Progesterone Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Progesterone Product Type
- 3.4.3 Date of International Manufacturers Enter into Progesterone Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Progesterone Sales by Product
- 4.2 Global Progesterone Revenue by Product
- 4.3 Progesterone Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Progesterone Breakdown Data by End User
6 North America
- 6.1 North America Progesterone by Countries
- 6.1.1 North America Progesterone Sales by Countries
- 6.1.2 North America Progesterone Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Progesterone by Product
- 6.3 North America Progesterone by End User
7 Europe
- 7.1 Europe Progesterone by Countries
- 7.1.1 Europe Progesterone Sales by Countries
- 7.1.2 Europe Progesterone Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Progesterone by Product
- 7.3 Europe Progesterone by End User
8 Asia Pacific
- 8.1 Asia Pacific Progesterone by Countries
- 8.1.1 Asia Pacific Progesterone Sales by Countries
- 8.1.2 Asia Pacific Progesterone Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Progesterone by Product
- 8.3 Asia Pacific Progesterone by End User
9 Central & South America
- 9.1 Central & South America Progesterone by Countries
- 9.1.1 Central & South America Progesterone Sales by Countries
- 9.1.2 Central & South America Progesterone Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Progesterone by Product
- 9.3 Central & South America Progesterone by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Progesterone by Countries
- 10.1.1 Middle East and Africa Progesterone Sales by Countries
- 10.1.2 Middle East and Africa Progesterone Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Progesterone by Product
- 10.3 Middle East and Africa Progesterone by End User
11 Company Profiles
- 11.1 ESTRELLAS LIFE SCIENCES PRIVATE LIMITED
- 11.1.1 ESTRELLAS LIFE SCIENCES PRIVATE LIMITED Company Details
- 11.1.2 Company Business Overview
- 11.1.3 ESTRELLAS LIFE SCIENCES PRIVATE LIMITED Progesterone Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 ESTRELLAS LIFE SCIENCES PRIVATE LIMITED Progesterone Products Offered
- 11.1.5 ESTRELLAS LIFE SCIENCES PRIVATE LIMITED Recent Development
- 11.2 BIONPHARMA INC.
- 11.2.1 BIONPHARMA INC. Company Details
- 11.2.2 Company Business Overview
- 11.2.3 BIONPHARMA INC. Progesterone Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 BIONPHARMA INC. Progesterone Products Offered
- 11.2.5 BIONPHARMA INC. Recent Development
- 11.3 SOFGEN PHARMACEUTICALS
- 11.3.1 SOFGEN PHARMACEUTICALS Company Details
- 11.3.2 Company Business Overview
- 11.3.3 SOFGEN PHARMACEUTICALS Progesterone Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 SOFGEN PHARMACEUTICALS Progesterone Products Offered
- 11.3.5 SOFGEN PHARMACEUTICALS Recent Development
- 11.4 TEVA PHARMACEUTICALS INDUSTRIES LTD.
- 11.4.1 TEVA PHARMACEUTICALS INDUSTRIES LTD. Company Details
- 11.4.2 Company Business Overview
- 11.4.3 TEVA PHARMACEUTICALS INDUSTRIES LTD. Progesterone Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 TEVA PHARMACEUTICALS INDUSTRIES LTD. Progesterone Products Offered
- 11.4.5 TEVA PHARMACEUTICALS INDUSTRIES LTD. Recent Development
- 11.5 VIRTUS PHARMACEUTICALS LLC
- 11.5.1 VIRTUS PHARMACEUTICALS LLC Company Details
- 11.5.2 Company Business Overview
- 11.5.3 VIRTUS PHARMACEUTICALS LLC Progesterone Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 VIRTUS PHARMACEUTICALS LLC Progesterone Products Offered
- 11.5.5 VIRTUS PHARMACEUTICALS LLC Recent Development
- 11.6 BLUBELL PHARMA GROUP COMPANY
- 11.6.1 BLUBELL PHARMA GROUP COMPANY Company Details
- 11.6.2 Company Business Overview
- 11.6.3 BLUBELL PHARMA GROUP COMPANY Progesterone Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 BLUBELL PHARMA GROUP COMPANY Progesterone Products Offered
- 11.6.5 BLUBELL PHARMA GROUP COMPANY Recent Development
- 11.7 AQUATIC REMEDIES PVT. LTD.
- 11.7.1 AQUATIC REMEDIES PVT. LTD. Company Details
- 11.7.2 Company Business Overview
- 11.7.3 AQUATIC REMEDIES PVT. LTD. Progesterone Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 AQUATIC REMEDIES PVT. LTD. Progesterone Products Offered
- 11.7.5 AQUATIC REMEDIES PVT. LTD. Recent Development
- 11.8 INTAS PHARMACEUTICALS LTD.
- 11.8.1 INTAS PHARMACEUTICALS LTD. Company Details
- 11.8.2 Company Business Overview
- 11.8.3 INTAS PHARMACEUTICALS LTD. Progesterone Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 INTAS PHARMACEUTICALS LTD. Progesterone Products Offered
- 11.8.5 INTAS PHARMACEUTICALS LTD. Recent Development
- 11.9 SHANGHAI YIJING INDUSTRIAL CO., LTD.
- 11.9.1 SHANGHAI YIJING INDUSTRIAL CO., LTD. Company Details
- 11.9.2 Company Business Overview
- 11.9.3 SHANGHAI YIJING INDUSTRIAL CO., LTD. Progesterone Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 SHANGHAI YIJING INDUSTRIAL CO., LTD. Progesterone Products Offered
- 11.9.5 SHANGHAI YIJING INDUSTRIAL CO., LTD. Recent Development
- 11.10 WUHAN HONOR BIO-PHARM CO., LTD.
- 11.10.1 WUHAN HONOR BIO-PHARM CO., LTD. Company Details
- 11.10.2 Company Business Overview
- 11.10.3 WUHAN HONOR BIO-PHARM CO., LTD. Progesterone Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 WUHAN HONOR BIO-PHARM CO., LTD. Progesterone Products Offered
- 11.10.5 WUHAN HONOR BIO-PHARM CO., LTD. Recent Development
12 Future Forecast
- 12.1 Progesterone Market Forecast by Regions
- 12.1.1 Global Progesterone Sales Forecast by Regions 2019-2025
- 12.1.2 Global Progesterone Revenue Forecast by Regions 2019-2025
- 12.2 Progesterone Market Forecast by Product
- 12.2.1 Global Progesterone Sales Forecast by Product 2019-2025
- 12.2.2 Global Progesterone Revenue Forecast by Product 2019-2025
- 12.3 Progesterone Market Forecast by End User
- 12.4 North America Progesterone Forecast
- 12.5 Europe Progesterone Forecast
- 12.6 Asia Pacific Progesterone Forecast
- 12.7 Central & South America Progesterone Forecast
- 12.8 Middle East and Africa Progesterone Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Progesterone Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Progesterone. Industry analysis & Market Report on Progesterone is a syndicated market report, published as Global Progesterone Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Progesterone market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
